Clover Health Posts First GAAP Profit Amid Strong Revenue Growth
Clover Health (NASDAQ:CLOV) reported its first quarter of GAAP net income in Q1 2026, turning a $27.3 million profit compared to a loss the previous year. The company's revenue surged by 62% to $749.19 million and Medicare Advantage membership increased by over 50%. CEO Andrew Toy reaffirmed guidance for full-year GAAP profitability in FY2026, with projected revenues between $2.81 billion and $2.92 billion. However, the company faces challenges including rising medical claims costs outpacing premium growth and an increase in unpaid claims to $260 million. The stock trades at a high forward P/E of 82, raising concerns about valuation despite strong operational improvements. Analysts remain cautious due to regulatory risks and cost trends. While Clover Health appears to be turning the corner operationally with profitability and membership growth, market participants are advised to monitor Q2 results for further confirmation.
Topics: GAAP profitability healthcare insurance Medicare Advantage